Research Summary
A digital biomarker refers to quantifiable and measurable physiological, behavioral, or biological data collected through digital devices and technologies, such as smartphones, wearables, or sensors. These data points are used to monitor and track health-related information, disease progression, treatment outcomes, and overall well-being. Digital biomarkers have the potential to provide continuous, real-time data, allowing for more comprehensive insights compared to traditional sporadic clinical assessments. They can include parameters like heart rate variability, activity levels, sleep patterns, cognitive performance, and even voice or speech characteristics. The integration of digital biomarkers into healthcare and medical research holds promise for early disease detection, personalized treatments, remote patient monitoring, and advancing our understanding of various health conditions.
According to DIResearch's in-depth investigation and research, the global Digital Biomarker market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Digital Biomarker include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Sanofi, GlaxoSmithKline, Bayer, Merck, Apple, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Digital Biomarker. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Digital Biomarker market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Digital Biomarker market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Digital Biomarker industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Digital Biomarker Include:
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Sanofi
GlaxoSmithKline
Bayer
Merck
Apple
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Digital Biomarker Product Segment Include:
Passive Digital Biomarker
Active Digital Biomarker
Digital Biomarker Product Application Include:
Clinical Disease
Daily Health
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Digital Biomarker Industry PESTEL Analysis
Chapter 3: Global Digital Biomarker Industry Porter's Five Forces Analysis
Chapter 4: Global Digital Biomarker Major Regional Market Size and Forecast Analysis
Chapter 5: Global Digital Biomarker Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Digital Biomarker Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Digital Biomarker Market Overview 1.1 Product Definition and Statistical Scope 1.2 Digital Biomarker Product by Type 1.2.1 Global Digital Biomarker Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Passive Digital Biomarker 1.2.3 Active Digital Biomarker 1.3 Digital Biomarker Product by Application 1.3.1 Global Digital Biomarker Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Clinical Disease 1.3.3 Daily Health 1.4 Global Digital Biomarker Market Revenue Analysis (2019-2030) 1.5 Digital Biomarker Market Development Status and Trends 1.5.1 Digital Biomarker Industry Development Status Analysis 1.5.2 Digital Biomarker Industry Development Trends Analysis 2 Digital Biomarker Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Digital Biomarker Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Digital Biomarker Market Analysis by Regions 4.1 Digital Biomarker Overall Market: 2023 VS 2024 VS 2030 4.2 Global Digital Biomarker Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Digital Biomarker Revenue and Market Share by Region (2019-2024) 4.2.2 Global Digital Biomarker Revenue Forecast by Region (2025-2030) 5 Global Digital Biomarker Market Size by Type and Application 5.1 Global Digital Biomarker Market Size by Type 5.2 Global Digital Biomarker Market Size by Application 6 North America 6.1 North America Digital Biomarker Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Digital Biomarker Market Size by Type 6.4 North America Digital Biomarker Market Size by Application 6.5 North America Digital Biomarker Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Digital Biomarker Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Digital Biomarker Market Size by Type 7.4 Europe Digital Biomarker Market Size by Application 7.5 Europe Digital Biomarker Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Digital Biomarker Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Digital Biomarker Market Size by Type 8.4 China Digital Biomarker Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Digital Biomarker Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Digital Biomarker Market Size by Type 9.4 APAC (excl. China) Digital Biomarker Market Size by Application 9.5 APAC (excl. China) Digital Biomarker Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Digital Biomarker Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Digital Biomarker Market Size by Type 10.4 Latin America Digital Biomarker Market Size by Application 10.5 Latin America Digital Biomarker Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Digital Biomarker Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Digital Biomarker Market Size by Type 11.4 Middle East & Africa Digital Biomarker Market Size by Application 11.5 Middle East & Africa Digital Biomarker Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Digital Biomarker Market Revenue by Key Manufacturers (2020-2024) 12.2 Digital Biomarker Competitive Landscape Analysis and Market Dynamic 12.2.1 Digital Biomarker Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Philips 13.1.1 Philips Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Philips Digital Biomarker Product Portfolio 13.1.3 Philips Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Johnson & Johnson 13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Johnson & Johnson Digital Biomarker Product Portfolio 13.2.3 Johnson & Johnson Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Pfizer 13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Pfizer Digital Biomarker Product Portfolio 13.3.3 Pfizer Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 GE Healthcare 13.4.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 GE Healthcare Digital Biomarker Product Portfolio 13.4.3 GE Healthcare Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Novartis 13.5.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Novartis Digital Biomarker Product Portfolio 13.5.3 Novartis Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Sanofi 13.6.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Sanofi Digital Biomarker Product Portfolio 13.6.3 Sanofi Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 GlaxoSmithKline 13.7.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 GlaxoSmithKline Digital Biomarker Product Portfolio 13.7.3 GlaxoSmithKline Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Bayer 13.8.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Bayer Digital Biomarker Product Portfolio 13.8.3 Bayer Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Merck 13.9.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Merck Digital Biomarker Product Portfolio 13.9.3 Merck Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Apple 13.10.1 Apple Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Apple Digital Biomarker Product Portfolio 13.10.3 Apple Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Abbott Laboratories 13.11.1 Abbott Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Abbott Laboratories Digital Biomarker Product Portfolio 13.11.3 Abbott Laboratories Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Asahi Kasei 13.12.1 Asahi Kasei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Asahi Kasei Digital Biomarker Product Portfolio 13.12.3 Asahi Kasei Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Biogen 13.13.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Biogen Digital Biomarker Product Portfolio 13.13.3 Biogen Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Koneksa Health 13.14.1 Koneksa Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Koneksa Health Digital Biomarker Product Portfolio 13.14.3 Koneksa Health Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 Roche 13.15.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Roche Digital Biomarker Product Portfolio 13.15.3 Roche Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.16 Huma Therapeutics 13.16.1 Huma Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Huma Therapeutics Digital Biomarker Product Portfolio 13.16.3 Huma Therapeutics Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Digital Biomarker Industry Chain Analysis 14.2 Digital Biomarker Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Digital Biomarker Typical Downstream Customers 14.4 Digital Biomarker Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024
- Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024
- Global Orthopaedics Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support